NO20080420L - Formulering med forlenget frigivelse av aktive bestanddeler med pH-avhengig loselighet - Google Patents
Formulering med forlenget frigivelse av aktive bestanddeler med pH-avhengig loselighetInfo
- Publication number
- NO20080420L NO20080420L NO20080420A NO20080420A NO20080420L NO 20080420 L NO20080420 L NO 20080420L NO 20080420 A NO20080420 A NO 20080420A NO 20080420 A NO20080420 A NO 20080420A NO 20080420 L NO20080420 L NO 20080420L
- Authority
- NO
- Norway
- Prior art keywords
- prolonged release
- dependent solubility
- active ingredients
- release formulation
- active ingredient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Abstract
Det beskrives en ny formulering for forlenget frigivning av en aktiv bestanddel med en pH avhengig oppløselighet. Formuleringen ifølge oppflrmelsen omfatter en matriksbærer basert på hydrofll polymer irmeholdende en spesiflkk dose av aktiv bestanddel, og omfatter videre ett eller flere surgjørende midler i form av et syresalt av en organisk syre.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0506539A FR2887455B1 (fr) | 2005-06-28 | 2005-06-28 | Formulation a liberation prolongee de principes actifs de medicaments |
PCT/FR2006/001466 WO2007003746A1 (fr) | 2005-06-28 | 2006-06-26 | Formulation a liberation prolongee de principes actifs presentant une solubilite dependante du ph |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20080420L true NO20080420L (no) | 2008-01-22 |
Family
ID=35708770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20080420A NO20080420L (no) | 2005-06-28 | 2008-01-22 | Formulering med forlenget frigivelse av aktive bestanddeler med pH-avhengig loselighet |
Country Status (31)
Country | Link |
---|---|
US (1) | US20080089936A1 (no) |
EP (1) | EP1904037A1 (no) |
JP (1) | JP2008546830A (no) |
KR (1) | KR101387839B1 (no) |
CN (1) | CN101217943B (no) |
AR (1) | AR057410A1 (no) |
AU (1) | AU2006264856B2 (no) |
BR (1) | BRPI0612990A2 (no) |
CA (1) | CA2611125A1 (no) |
CR (1) | CR9567A (no) |
DO (1) | DOP2006000144A (no) |
EA (1) | EA013745B1 (no) |
EC (1) | ECSP078010A (no) |
FR (1) | FR2887455B1 (no) |
GT (1) | GT200600275A (no) |
HK (1) | HK1122731A1 (no) |
HN (1) | HN2006023741A (no) |
IL (1) | IL187901A0 (no) |
MA (1) | MA29560B1 (no) |
MX (1) | MX2007016238A (no) |
MY (1) | MY150069A (no) |
NO (1) | NO20080420L (no) |
NZ (1) | NZ564069A (no) |
PA (1) | PA8682701A1 (no) |
PE (1) | PE20070098A1 (no) |
TN (1) | TNSN07438A1 (no) |
TW (1) | TWI446934B (no) |
UA (1) | UA91553C2 (no) |
UY (1) | UY29637A1 (no) |
WO (1) | WO2007003746A1 (no) |
ZA (1) | ZA200711035B (no) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2090297A1 (en) * | 2008-02-13 | 2009-08-19 | Boehringer Ingelheim International GmbH | Formulations of flibanserin |
WO2013040442A1 (en) * | 2011-09-14 | 2013-03-21 | Pozen Inc. | Phased dosing of clopidogrel |
IT201700011337A1 (it) * | 2017-02-02 | 2018-08-02 | S I I T S R L Servizio Int Imballaggi Termosaldanti | Compressa multistrato per la somministrazione di magnesio |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2655266B1 (fr) * | 1989-12-05 | 1992-04-03 | Smith Kline French Lab | Compositions pharmaceutiques a base de cimetidine. |
DE59303759C5 (de) * | 1992-01-17 | 2009-04-09 | Alfatec-Pharma Gmbh | Wirkstoff-enthaltende festkörper mit einem gerüst aus hydrophilen makromolekülen und verfahren zu ihrer herstellung |
EP1005863A1 (en) * | 1998-12-04 | 2000-06-07 | Synthelabo | Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof |
AU3469100A (en) * | 1999-01-05 | 2000-07-24 | Copley Pharmaceutical Inc. | Sustained release formulation with reduced moisture sensitivity |
EP1064937A1 (en) * | 1999-06-28 | 2001-01-03 | Sanofi-Synthelabo | Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof |
JP4933033B2 (ja) * | 2003-03-17 | 2012-05-16 | 武田薬品工業株式会社 | 放出制御組成物 |
EP1686976A2 (en) * | 2003-11-05 | 2006-08-09 | Santarus, Inc. | Combination of proton pump inhibitor and sleep aid |
-
2005
- 2005-06-28 FR FR0506539A patent/FR2887455B1/fr not_active Expired - Fee Related
-
2006
- 2006-06-23 PA PA20068682701A patent/PA8682701A1/es unknown
- 2006-06-26 CN CN2006800231372A patent/CN101217943B/zh active Active
- 2006-06-26 MX MX2007016238A patent/MX2007016238A/es active IP Right Grant
- 2006-06-26 EP EP06778663A patent/EP1904037A1/fr not_active Withdrawn
- 2006-06-26 MY MYPI20063017A patent/MY150069A/en unknown
- 2006-06-26 CA CA002611125A patent/CA2611125A1/fr not_active Abandoned
- 2006-06-26 AU AU2006264856A patent/AU2006264856B2/en not_active Ceased
- 2006-06-26 JP JP2008518906A patent/JP2008546830A/ja active Pending
- 2006-06-26 EA EA200800150A patent/EA013745B1/ru not_active IP Right Cessation
- 2006-06-26 DO DO2006000144A patent/DOP2006000144A/es unknown
- 2006-06-26 UA UAA200800914A patent/UA91553C2/ru unknown
- 2006-06-26 NZ NZ564069A patent/NZ564069A/en not_active IP Right Cessation
- 2006-06-26 WO PCT/FR2006/001466 patent/WO2007003746A1/fr active Application Filing
- 2006-06-26 KR KR1020077030484A patent/KR101387839B1/ko active IP Right Grant
- 2006-06-26 ZA ZA200711035A patent/ZA200711035B/xx unknown
- 2006-06-26 BR BRPI0612990-0A patent/BRPI0612990A2/pt not_active Application Discontinuation
- 2006-06-27 AR ARP060102755A patent/AR057410A1/es unknown
- 2006-06-27 GT GT200600275A patent/GT200600275A/es unknown
- 2006-06-27 HN HN2006023741A patent/HN2006023741A/es unknown
- 2006-06-28 PE PE2006000753A patent/PE20070098A1/es active IP Right Grant
- 2006-06-28 TW TW095123267A patent/TWI446934B/zh not_active IP Right Cessation
- 2006-06-29 UY UY29637A patent/UY29637A1/es unknown
-
2007
- 2007-11-26 TN TNP2007000438A patent/TNSN07438A1/en unknown
- 2007-12-03 US US11/949,291 patent/US20080089936A1/en not_active Abandoned
- 2007-12-04 IL IL187901A patent/IL187901A0/en unknown
- 2007-12-06 CR CR9567A patent/CR9567A/es unknown
- 2007-12-13 EC EC2007008010A patent/ECSP078010A/es unknown
- 2007-12-24 MA MA30501A patent/MA29560B1/fr unknown
-
2008
- 2008-01-22 NO NO20080420A patent/NO20080420L/no not_active Application Discontinuation
- 2008-12-29 HK HK08114006.5A patent/HK1122731A1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1125035T1 (el) | Ουσια-φορεας φαρμακων και κιτ ουσιας-φορεα φαρμακων για αναστολη ινωσης | |
DK1372608T3 (da) | Medicinske aerosolformuleringer | |
ATE362314T1 (de) | Herbizidzusammensetzungen umfassend imidazolinonsäure | |
BRPI0515012A (pt) | substáncia quìmica, composição e formulação farmacêutica, método de tratamento, método de inibição de pelo menos uma enzima que utiliza atp e uso | |
WO2007037795A3 (en) | Stable aqueous protein or antibody pharmaceutical formulations and their preparation | |
RS50360B (sr) | Farmaceutske formulacije derivata platine | |
CY1109272T1 (el) | Συνθεση παρατεταμενης απελευθερωσεως περιλαμβανουσα συμπολυμερες γαλακτικου οξεος-γλυκολικου οξεος και μεθοδος παρασκευης της | |
ATE470443T1 (de) | Indol-1-yl-essigsäurederivate | |
NO20071667L (no) | Farmasoytisk preparat omfattende levetiracetam og fremgangsmate for fremstilling av preparatet | |
EA200870379A1 (ru) | Фармацевтическая композиция с замедленным высвобождением на основе системы высвобождения, включающей кислоторастворимый полимер и ph-зависимый полимер | |
CY1108766T1 (el) | Συνθεσεις και μεθοδοι για την προληψη ή την μειωση της αντοχης των εντομων στα εντομοκτονα | |
NO20080220L (no) | Formuleringer med hoy medikament belastning og doseringsformer | |
NO20080420L (no) | Formulering med forlenget frigivelse av aktive bestanddeler med pH-avhengig loselighet | |
CY1109541T1 (el) | Φαρμακευτικη συνταγοποιηση για την θεραπεια οστεοαρθριτιδας η οποια περιεχει κλοδρονικο οξυ και υαλουρονικο οξυ | |
BRPI0513244A (pt) | composto de clatrato, método para controlar a concentração de solução aquosa de ingrediente ativo quìmico agrìcola e formulação quìmica agrìcola | |
FR2882522B1 (fr) | Composition pharmaceutique solide comprenant de la telithromycine | |
AR040287A1 (es) | Plataforma para formulaciones transdermicas (pft) | |
ITRM20040168A1 (it) | Composizione a rilascio modificato ph dipendente. | |
EA200601015A1 (ru) | Пероральные композиции дезоксипеганина и их применение | |
ATE487492T1 (de) | Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit | |
DK1254944T3 (da) | Törre sammensætninger, der indeholder hydrofob aminosyre | |
AR029718A1 (es) | Composicion farmaceutica a base de cocaetileno y su utilizacion para el tratamiento de la dependencia de las substancias psicoactivas | |
UY26840A1 (es) | Composición farmacéutica a base de cocaetileno y su utilización para el tratamiento de la dependencia a las sustancias psicoactivas | |
FR2865402B1 (fr) | Composition amaigrissante par voie orale comprenant de l'acide linoleique conjugue et de la cafeine. | |
DK1889629T3 (da) | Stabil formulering omfattende en kombination af et fugtsensitivt stof og et andet stof og fremgangsmåde til fremstilling deraf |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |